Low number of KIR ligands in lymphoma patients favors a good rituximab-dependent NK cell response-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Low number of KIR ligands in lymphoma patients favors a good rituximab-dependent NK cell response

Published:2021-01-01 Issue:1 Volume:10 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Makanga Dhon Roméo¹²³,Jullien Maxime⁴^ORCID,David Gaëlle¹²³,Legrand Nolwenn¹²³,Willem Catherine¹²³,Dubreuil Léa¹²³,Walencik Alexandre¹,Touzeau Cyrille⁴,Gastinne Thomas⁴,Tessoulin Benoit⁴,Le Gouill Steven⁴,Mahé Béatrice⁴,Gagne Katia¹²³⁵,Chevallier Patrice²³⁴,Clemenceau Béatrice²³,Retière Christelle¹²³^ORCID

Affiliation:

1. Etablissement Français Du Sang, Nantes, Nantes, France

2. Université De Nantes, INSERM U1232 CNRS, CRCINA, Nantes, France

3. LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, France

4. Hematology Clinic, CHU, Nantes, France

5. LabEx Transplantex, Université De Strasbourg, Strasbourg, France

Funder

Région Pays de la Loire/EFS

Région Centre Pays de la Loire/EFS

ANRT

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2021.1936392

Reference41 articles.

1. From the bench to the bedside: ways to improve rituximab efficacy

2. Mechanisms of killing by anti-CD20 monoclonal antibodies

3. Clinical Cancer Therapy by NK Cells via Antibody-Dependent Cell-Mediated Cytotoxicity

4. Selection and expansion of natural killer cells for NK cell-based immunotherapy

5. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multifactorial determinants of NK cell repertoire organization: insights into age, sex, KIR genotype, HLA typing, and CMV influence;Frontiers in Immunology;2024-04-26

2. KIR2DS1 and KIR2DL1-C245 Dominantly Repress NK Cell Degranulation Triggered by Monoclonal or Bispecific Antibodies, whereas Education by Uptuning Inhibitory Killer Ig-related Receptors Exerts No Advantage in Ab-dependent Cellular Cytotoxicity;The Journal of Immunology;2024-01-19

3. Therapeutic options for rituximab-resistant patients;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

4. Antibody–drug conjugates come of age in oncology;Nature Reviews Drug Discovery;2023-06-12

5. Cord blood stem cell-generated KIR+NK cells effectively target leukemia cell lines;Human Immunology;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3